Contact HIV/AIDS
Info on HIV/AIDS:
206-205-7837
TTY: 206-296-4843
Toll-free: 800-678-1595
Administration:
206-296-4649
HIV/STD Testing
HIV/STD Hotline:
206-205-7837 or
Toll-free: 800-678-1595
11:00 am to 4:00 pm
Monday - Friday for
testing information, resources and referrals
Subscribe to Free Email Alerts!
Click here to learn more
|
|
HIV/AIDS Program
Bibliographies for September - October 2003
| 1. |
McCloskey BP. The Role of Housing in Better Care Outcomes for People with AIDS. FOCUS, Sept 2003; 18(9): 1-8.
|
| 2. |
del Rio C. New Challenges in HIV Care: Prevention Among HIV-Infected Patients. Topics in HIV Medicine (International AIDS Society-USA), July/August 2003; 11(4): 140-144.
|
| 3. |
Schreibman T and Friedland G. HIV Prevention: Strategies for Clinicians. Clinical Infectious Diseases, May 2003; 36: 1171-1176.
|
| 4. |
Riley ED, Wu AW Petty S et al. Depression and Drug Use Impact Health Status Among Marginally Housed HIV-Infected Individuals. AIDS Pt Care & STDs, 2003; 17(8): 401-406.
|
| 5. |
O'Brien ME, Richardson-Alston G, Ayoub M et al. Prevalence and Correlates of HIV Serostatus Disclosure. Sexually Transmitted Diseases, Sept 2003; 30(9): 731-735.
|
| 6. |
Wold K, Young J, Rickenbach M. Prevalence of Unsafe Sexual Behavior Among HIV-Infected Individuals: The Swiss HIV Cohort Study. JAIDS, Aug 1, 2003; 33(4): 494-499.
|
| 7. |
Garcia PR and Cote JK. Factors Affecting Adherence to Antiretroviral Therapy in People Living with HIV/AIDS. J Assoc Nurses AIDS Care, July/Aug 2003; 14(4): 37-45.
|
| 8. |
Conigliaro J, Gordon AJ McGinnis KA et al. How Harmful is Hazardous Alcohol Use and Abuse in HIV Infection: Do Health Care Providers Know Who is at Risk? JAIDS, Aug 1, 2003; 33(4): 521-525.
|
| 9. |
Abrams DI, Hilton JF, Leiser RJ et al. Short-Term Effects of Cannabinoids in Patients with HIV-1 Infection: A Randomized Placebo-Controlled Clinical Trial. Ann Intern Med, Aug 19, 2003; 139(4): 258-266.
|
| 10. |
Fichtenbaum CJ. Antiretrovirals and Cardiovascular Disease: Is HAART Bad for Your Heart? AIDS Clinical Care, Aug 2003; 15(8) : 69-74.
|
| 11. |
Currier JS, Taylor A, Boyd F et al. Coronary Heart Disease in HIV-Infected Individuals. JAIDS, Aug 1, 2003; 33(4): 506-512.
|
| 12. |
Carr A. Cardiovascular Risk Factors in HIV-Infected Patients. JAIDS, Sept 2003; 34(Suppl 1): S73-S78.
|
| 13. |
Farley TA, Cohen DA, Wu S-Y and Besch CL. The Value of Screening for Sexually Transmitted Diseases in an HIV Clinic. JAIDS, Aug 15, 2003; 33(5): 642-648.
|
| 14. |
Highleyman L. Monitoring Tests for People with HIV. BETA, Summer 2003: 31-39.
|
| 15. |
Selwyn PA and Forstein M. Overcoming the False Dichotomy of Curative Vs Palliative Care for Late-Stage HIV/AIDS: "Let Me Live the Way I Want to Live, Until I Can't". JAMA, Aug 13, 2003; 290(6): 806-814.
|
| 16. |
Rockstroh JK. Management of Hepatitis B and C in HIV Co-Infected Patients. JAIDS, Sept, 2003; 34(Suppl 1): S59-S65.
|
| 17. |
Sullivan JL. Prevention of Mother-to-Child Transmission of HIV--What Next? JAIDS, Sept 2003; 34(Suppl 1):S67-S72.
|
| 18. |
CDC. Rapid Point-of-Care Testing for HIV-1 During Labor and Delivery--Chicago, Illinois, 2002. MMWR, Sept 12, 2003; 52(36): 866-868.
|
| 19. |
Jackson JB, Musoke P, Fleming T et al. Intrapartum and Neonatal Single-Dose Nevirapine Compared with Zidovudine for Prevention of Mother-to-Child Transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 Randomised Trial. Lancet, Sept 13, 2003; 362: 859-868.
|
| 20. |
Schleiss MR. Vertically Transmitted Herpesvirus Infections. Herpes, 2003; 10(1): 4-11.
|
| 21. |
Hunt N. A Review of the Evidence-Base for Harm Reduction Approaches to Drug Use. On-line at: http://forward-thinking-on-drugs.org/review2.html. Accessed Oct 1, 2003.
|
| 22. |
Wilson AR and Kahn JG. Preventing HIV in Injection Drug Users: Choosing the Best Mix of Interventions for the Population. J Urban Health, Sept 2003; 80(3): 465-481.
|
| 23. |
Inungu J, Beach EM and Skeel R. Challenges Facing Health Professionals Caring for HIV-Infected Drug Users. AIDS Pt Care & STDs, 2003; 17(7): 333-343.
|
| 24. |
Bailey SL, Huo D, Garfein RS and Ouellet LJ. The Use of Needle Exchange by Young Injection Drug Users. JAIDS, Sept 1, 2003; 34(1): 67-70.
|
| 25. |
Kerr T, Wood E, Small D, Palepu A and Tyndall MW. Potential Use of Safer Injecting Facilities Among Injection Drug Users in Vancouver's Downtown Eastside. Can Med Assoc J, Oct 14, 2003: 169(8): 759-763.
|
| 26. |
Fry CL. Safer Injecting Facilities in Vancouver: Considering Issues Beyond Potential Use. (Commentary) Can Med Assoc J, Oct. 14, 2003; 169(8): 777-778.
|
| 27. |
Bird SM, Hutchinson SJ and Goldberg DJ. Drug-Related Deaths by Region, Sex, and Age Group per 100 Injecting Drug Users in Scotland, 2000-2001. Lancet, 2003; 362: 941-944.
|
| 28 |
CDC. Wound Botulism Among Black Tar Heroin Users—Washington, 2003. MMWR, Sept 19, 2003; 52(37): 885-886.
|
| 29. |
Tun W, Celentano DD, Vlahov D and Strathdee SA. Attitudes Toward HIV Treatments Influence Unsafe Sexual and Injection Practices Among Injecting Drug Users. AIDS, 2003; 17(13): 1953-1962.
|
| 30. |
Latkin CA, Sherman S and Knowlton A. HIV Prevention Among Drug Users: Outcome of a Network-Oriented Peer Outreach Intervention. Health Psychology, 2003; 22(4): 332-339.
|
| 31. |
Altice FL, Springer S, Buitrago M, Hunt DP and Friedland GH. Pilot Study to Enhance HIV Care Using Needle Exchange-Based Health Services for Out-of-Treatment Injecting Drug Users. J Urban Health, Sept 2003; 80(3): 416-427.
|
| 32. |
Wood E, Kerr T, Spittal PM et al. An External Evaluation of a Peer-Run "Unsanctioned" Syringe Exchange Program. J Urban Health, Sept 2003; 80(3): 455-464.
|
| 33. |
Wood E, Kerr T, Small W et al. The Impact of a Police Presence on Access to Needle Exchange Programs. (Letter) JAIDS, Sept 1, 2003; 34(1): 116-117.
|
| 34. |
van den Brink W, Hendriks VM Blanken P et al. Medical Prescription of Heroin to Treatment Resistant Heroin Addicts: Two Randomised Controlled Trials. British Med J, Aug 9, 2003; 327: 310-316.
|
| 35. |
Fudala PJ, Bridge TP, Herbert S et al. Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and Naloxone. NEJM, Sept 4, 2003; 349(10): 949-958.
|
| 36. |
Clark HW. Office-Based Practice and Opioid-Use Disorders. (Editorial) NEJM, Sept 4, 2003; 349(10): 928-930.
|
| 37. |
Vastag B. In-Office Opiate Treatment "Not a Panacea": Physicians Slow to Embrace Therapeutic Option. (News & Perspectives) JAMA, Aug 13, 2003; 290(6): 731-736.
|
| 38. |
Phillips AN, Lepri AC, Lampe F, Johnson M and Sabin CA. When Should Antiretroviral Therapy be Started for HIV Infection? Interpreting the Evidence from Observational Studies. AIDS, 2003; 17((13): 1863-1869.
|
| 39. |
Kaplan JE, Hanson DL, Cohn DL et al. When to Begin Highly Active Antiretroviral Therapy? Evidence Supporting Initiation of Therapy at CD4+ Lymphocyte Counts <350 cells/uL. Clinical Infectious Diseases, 2003.
|
| 40. |
Lawrence J, Mayers DL, Hullsiek KH et al. Structured Treatment Interruption in Patients with Multidrug-Resistant HIV. NEJM, Aug 28, 2003; 349(9): 837-846.
|
| 41. |
The ART Cohort Collaboration. Prognostic Importance of Initial Response in HIV-1 Infected Patients Starting Potent Antiretroviral Therapy: Analysis of Prospective Studies. Lancet, Aug 30, 2003; 362: 679-686.
|
| 42. |
Jaggy C, von Overbeck J, Ledergerber B et al. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss General Population. Lancet, Sept 13, 2003; 362: 877-878.
|
| 43. |
Tassie J-M, Szumilin E, Calmy A and Goemaere E. HAART in Resource-Poor Settings: the Experience of Medecins Sans Frontieres. AIDS, 2003; 17(13): 1995-1997.
|
| 44. |
The Working Group on ART and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Sept 22, 2003. On-line at: http://AIDSinfo.nih.gov.
|
| 45. |
The Perinatal HIV Guidelines Working Group. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States. Sept 22, 2003. On-line at: http://AIDSinfo.nih.gov.
|
| 46. |
Mayer KH, Hogan JW, Smith D et al. Clinical and Immunologic Progression in HIV-Infected US Women Before and After the Introduction of HAART. JAIDS, Aug 15, 2003; 33(5): 614-624.
|
| 47. |
Wilson TE, Koenig L, Ickovics H. Contraception Use, Family Planning, and Unprotected Sex: Few Differences Among HIV-Infected and Uninfected Postpartum Women in Four US States. JAIDS, Aug 15, 2003; 33(5): 608-613.
|
| 48. |
Theall KP, Sterk CE, Elifson KW, and Kidder D. Factors Associated with Positive HIV Serostatus Among Women Who Use Drugs: Continued Evidence for Expanding Factors of Influence. Public Health Reports, Sept-Oct 2003; 118: 415-424.
|
| 49. |
Oh MK, Funkhouser E, Simpson T et al. Early Onset of Vaginal Douching is Associated With False Beliefs and High-Risk Behavior. Sexually Transm Diseases, Sept 2003; 30(9): 689-693.
|
Men Who Have Sex With Men
|
| 50. |
Koblin BA, Perdue T, Ren L, Thiede H et al. Attitudes About Combination HIV Therapies: The Next Generation of Gay Men at Risk. J Urban Health, Sept 2003; 80(3): 510-519.
|
| 51. |
Van Der Snoek EM, Niesters GM, Mulder PGH et al. HPV Infection in Men Who Have Sex With Men Participating in a Dutch Gay-Cohort Study. Sexually Transmitted Diseases, Aug 2003; 30(8): 639-644.
|
| 52. |
Special Issue: Gay Bathhouses and Public Health Policy. J Homosexuality, 44(3/4): 10 articles, 240 pages.
|
Sexually Transmitted Diseases
|
| 53. |
Golden MR, Marra CM and Holmes KK. Update on Syphilis: Resurgence of an Old Problem. JAMA, Sept 17, 2003; 290(11): 1510-1514.
|
| 54. |
Rosen T. Update on Genital Lesions. JAMA, Aug 27, 2003; 290(8): 1001-1005.
|
| 55. |
Kahn RH, Moseley KE, Thilges JN et al. Community-Based Screening and Treatment for STDs: Results from a Mobile Clinic Initiative. Sexually Transmitted Diseases, Aug 2003; 30(8): 654-658.
|
| 56. |
Rietmeijer CA. The Role of STD Outreach Testing in Times of Dwindling STD Prevention Resources. (Editorial) Sexually Transmitted Diseases, Aug 2003; 30(8): 659-660.
|
| 57. |
Kannel WB, Levine BS. Candida Infection as a Risk Factor for HIV Transmission. J Women’s Health, 2003; 12(5): 487-494. On-line at: www.medscape.com/viewarticle/458566_print.
|
| 58. |
Lyss SB, Kamb ML, Peterman TA. Chlamydia trachomatis Among Patients Infected with and Treated for Neisseria gonorrhoeae in STD Clinics in the U.S. Annals of Internal Medicine, Aug 5, 2003; 139(3): 178-185.
|
| 59. |
Boselli F, Chiossi G and Gallinelli A. The Italian STD "Hot-Line": Making People Aware. Sexually Transmitted Diseases, Sept 2003; 30(9): 707-712.
|
| 60. |
Rust G, Minor P, Jordan N et al. Do Clinicians Screen Medicaid Patients for Syphilis or HIV When They Diagnose Other STDs? Sexually Transmitted Diseases, Sept 2003; 30(9): 723-727.
|
| 61. |
Ferenczy A, Coutlee F, Franco E and Hankins C. HPV and HIV Coinfection and the Risk of Neoplasias of the Lower Genital Tract: a Review of Recent Developments. Canadian Medical Association Journal, Sept 2, 2003; 169(5): 431-434.
|
| 62. |
Advocates for Youth. Science and Success: Sex Education and Other Programs that Work to Prevent Teen Pregnancy, HIV, & STDs. 2003. On-Line at: www.advocatesforyouth.org.
|
| 63. |
Morrison DM, Gillmore JR, Hoppe MJ et al. Adolescent Drinking and Sex: Findings from a Daily Diary Study. Perspect Sexual & Reproductive Health, 2003; 35(4): 162-168.
|
| 64. |
Crosby RA, Diclemente RJ, Wingood GM et al. Adjudication History and African American Adolescents' Risk for Acquiring STDs: An Exploratory Analysis. Sexually Transmitted Diseases, Aug 2003; 30(8): 634-638.
|
| 65. |
Robertson JE. Rape Among Incarcerated Men: Sex, Coercion and STDs. AIDS Pt Care & STDs, 2003; 17(8): 423-430.
|
| 66. |
Special Issue: The Debate: Sexual Addiction and Compulsion. SIECUS REPORT, June/July 2003; 31(5): 4-18. This issue includes five articles dealing with sexual addiction & compulsion.
|
| 67. |
Wood RW, Dunphy C, Okita K and Swenson P. Two "HIV-Infected" Persons Not Really Infected. Arch Intern Med, Aug 11/25 2003; 163:1857-1859.
|
| 68. |
Lee LM, McKenna MT and Janssen RS. Classification of Transmission Risk in the National HIV/AIDS Surveillance System. Public Health Reports, Sept-Oct 2003; 118: 400-407.
|
| 69. |
Dukers NHTM and Rezza G. Human Herpesvirus 8 Epidemiology: What we do and do not Know. AIDS, 2003; 17(12): 1717-1730.
|
| 70. |
Walsh TL, Frezieres RG, Peacock K et al. Evaluation of the Efficacy of a Nonlatex Condom: Results from a Randomized, Controlled Clinical Trial. Perspectives on Sexual & Reproductive Health, Mar/Apr 2003; 35(2): 79-86.
|
| 71. |
Dasgupta A. Review of Abnormal Laboratory Test Results and Toxic Effects Due to Use of Herbal Medicines. Am J Clin Pathol, 2003; 120(1): 127-137. On-line at: www.medscape.com/viewarticle/458306.
|
| 72. |
Fiebig EW, Wright DJ, Rawal BD et al. Dynamics of HIV Viremia and Antibody Seroconversion in Plasma Donors: Implications for Diagnosis and Staging of Primary HIV Infection. AIDS, 2003; 17(13): 1871-1879.
|
| 73. |
Glynn JR, Carael M, Buve A et al. HIV Risk in Relation to Marriage in Areas with High Prevalence of HIV Infection. JAIDS, Aug 1, 2003; 33(4): 526-535.
|
|
|
|
